Fluphenazine hydrochloride NDC 27241-254

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-254Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0254Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-254-01	27241025401	100 TABLET in 1 BOTTLE (27241-254-01)Marketed from Jan 5, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluphenazine hydrochloride
Generic name (nonproprietary): fluphenazine hydrochloride
Active ingredients: Fluphenazine hydrochloride — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217410
Marketing start: Jan 5, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 27241-254_0069bda4-a743-4edd-a15f-a53cba1a2bffSPL ID 0069bda4-a743-4edd-a15f-a53cba1a2bffSPL set ID 47695e20-9c0b-4a6b-ab1a-1dfaa75e96d8RxCUI 859841, 860918, 865117, 865123UNII ZOU145W1XLUPC 0327241255014, 0327241252013, 0327241253010, 0327241254017
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241025401 followed by a unit qualifier and the quantity

Package 27241-0254-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 4, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluphenazine hydrochloride tablets, USP are indicated in the management of manifestations of psychotic disorders. Fluphenazine hydrochloride USP has not been shown effective in the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217410

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217410
Product	Strength	Form · route	Labeler	Product NDC
Fluphenazine hydrochloride	Fluphenazine hydrochloride 5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4273
Fluphenazine hydrochloride	Fluphenazine hydrochloride 5 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-253
Fluphenazine hydrochloride	Fluphenazine hydrochloride 10 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-252
Fluphenazine hydrochloride	Fluphenazine hydrochloride 1 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-255